Drug intelligence / Profile preview

Mykoderm

Development stage
Unknown
Lead developer
Engelhard Arzneimittel
Modality
Small Molecules
Administration
Topical, Buccal, Oral, Vaginal
01

Overview

Mykoderm is a brand of antifungal medications developed and manufactured by Engelhard Pharma, primarily available in the German market. The Mykoderm product line encompasses several distinct formulations that utilize either **nystatin** or **miconazole** as the active pharmaceutical ingredient to treat various fungal infections. Mykoderm Heilsalbe (Healing Ointment) contains nystatin and is specifically indicated for yeast infections of the skin, such as diaper dermatitis (diaper rash) and candidiasis in skin folds. Nystatin works by binding to ergosterol in the fungal cell membrane, creating pores that lead to the leakage of intracellular components and cell death. Other products in the line, such as Mykoderm Mund-Gel and Mykoderm Miconazolcreme, contain miconazole, an imidazole antifungal. Miconazole inhibits the enzyme lanosterol 14-alpha demethylase, which is essential for the biosynthesis of ergosterol; its inhibition disrupts the integrity of the fungal cell membrane and inhibits growth. These miconazole-based products are typically used for oral thrush and various dermatomycoses.

Brand names
Mykoderm
Other names
nystatinmiconazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)Ergosterol

Beyond the preview

Go deeper on Mykoderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mykoderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call